Susannah Cantrell
Corporate Officer/Principal bij BRII BIOSCIENCES LIMITED
Profiel
Susannah Cantrell is currently the Chief Business Officer at Brii Biosciences Ltd.
(China) since 2022.
Prior to this, she worked as the VP & Head-Global Commercial Strategy at Gilead Sciences, Inc. from 2011 to 2019.
She was also the Chief Commercial Officer & Executive VP at Tricida, Inc. in 2020.
Dr. Cantrell held the position of Head-Sales & Marketing at GlaxoSmithKline LLC and was the Chief Operating & Business Officer at Second Genome, Inc. She holds a doctorate degree from the University of Missouri and an undergraduate degree from Westminster College (Pennsylvania).
Actieve functies van Susannah Cantrell
| Bedrijven | Functie | Begin |
|---|---|---|
| BRII BIOSCIENCES LIMITED | Corporate Officer/Principal | 11-07-2022 |
Eerdere bekende functies van Susannah Cantrell
| Bedrijven | Functie | Einde |
|---|---|---|
| TRICIDA, INC. | Corporate Officer/Principal | 30-10-2020 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01-01-2019 |
Second Genome, Inc.
 Second Genome, Inc. BiotechnologyHealth Technology Second Genome, Inc. develops microbiome-based therapeutic products. It offers phyclochip community, 16S sequencing community analysis, whole metagenomic profiling, nucleic acid isolation, inferred function and custom informatics services. The company was founded in 2009 by Corey S. Goodman, Janet A. Warrington, Todd Z. DeSantis, John Hulls and Gary Andersen and is headquartered in South San Francisco, CA. | Operationeel Directeur | - |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Verkoop & Marketing | - |
Opleiding van Susannah Cantrell
| Westminster College (Pennsylvania) | Undergraduate Degree |
| University of Missouri | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| TRICIDA, INC. | Health Technology |
| GILEAD SCIENCES, INC. | Health Technology |
| BRII BIOSCIENCES LIMITED | Commercial Services |
| Bedrijven in privébezit | 2 |
|---|---|
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Health Technology |
Second Genome, Inc.
Second Genome, Inc. BiotechnologyHealth Technology Second Genome, Inc. develops microbiome-based therapeutic products. It offers phyclochip community, 16S sequencing community analysis, whole metagenomic profiling, nucleic acid isolation, inferred function and custom informatics services. The company was founded in 2009 by Corey S. Goodman, Janet A. Warrington, Todd Z. DeSantis, John Hulls and Gary Andersen and is headquartered in South San Francisco, CA. | Health Technology |
